Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more
2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more
2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more
Preclinical biotech Passage Bio (PASG) is the only IPO set to price in the coming week. Passage Bio plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint, Passage Bio would command a...read more
US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week
Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more
Updated: Renaissance Capital's 1Q 2020 US IPO Market Review
2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more
Renaissance Capital's 1Q 2020 US IPO Market Review
2020 IPO Boom Stopped Cold by Coronavirus Meltdown The 2020 IPO market began with optimism and ended with the worst crash since the global financial crisis. ...read more
US IPO Week Ahead: One biotech to close out February
Preclinical biotech Passage Bio (PASG) is the only IPO set to price in the coming week. Passage Bio plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint, Passage Bio would command a...read more